Reversing DOAC Bleeding: Real world case studies

 
Loading

Reversing DOAC Bleeding: Real world case studies

10 Nov 2021
AGM Theatre 2

Join Dr Jehangir and Dr Sehgal in a review of life-threatening or uncontrolled bleed cases in patients treated with a direct factor Xa inhibitor (apixaban or rivaroxaban). They will discuss the initial assessments carried out, the MDT involvement, treatment/reversal decisions and patient outcomes. This will including when and where reversal agents should and should not be used and timing of endoscopy

Speakers
Amir Jehangir, Consultant in Acute and General Medicine - University College Hospital London
GOLD SPONSOR

GOLD SPONSOR

  

GOLD SPONSOR

  • A. Menarini Farmaceutica Internazionale Srl

 

GOLD SPONSOR

  • Alexion Pharma

 

GOLD SPONSOR

  • BMS-Pfizer

 

GOLD SPONSOR

  • FUJIFILM SONOSITE

 

GOLD SPONSOR

SD

SILVER SPONSOR

  • Boston Scientific

 

SILVER SPONSOR

  • Bial Pharma

 

SILVER SPONSOR

  • The MDU

 

SILVER SPONSOR

  • MDDUS

 

SILVER SPONSOR

GF

SILVER SPONSOR

JK

SILVER SPONSOR

SILVER SPONSOR

  

Lanyard Sponsor

Lanyard Sponsor

      

Lanyard Sponsor

Lanyard Sponsor

      

Don't miss your chance to get involved